Clinical outcomes with of the Contix Faecal Incontinence Management System: preliminary results
10.3393/ac.2022.00563.0080
- Author:
Moris VENTURERO
1
;
Reuma YEHUDA-MARGALIT
;
Carla MARADEY-ROMERO
;
Yael CORCOS
;
Dan CARTER
;
Marc BEER-GABEL
Author Information
1. Department of Surgery, Laniado Hospital, Sanz Medical Center, Netanya, Israel
- Publication Type:Technical Note
- From:Annals of Coloproctology
2023;39(1):89-93
- CountryRepublic of Korea
- Language:English
-
Abstract:
Fecal incontinence (FI) has a significant long-term impact on patient quality of life for which there is a range of medical and surgical management alternatives. We report the preliminary outcome using the ForConti Contix Faecal Incontinence Management System (FIMS) in FI patients who had failed conservative therapy and who were recruited at 2 tertiary institutions between September 2018 and September 2020. Comparative assessments were made before and after 2 week periods of treatment using bowel diaries and subjective Wexner and Faecal Incontinence Quality of Life scores. Of 17 patients enrolled, 11 completed an 8-week assessment with a significant fall in the average percentage of FI days reported from 84% before treatment to 16.8% at the first posttreatment assessment and down to 13.2% by the second assessment period. This finding correlated with a similar reduction in the total weekly number of episodes of frank FI, minor soiling, and fecal urgency reported by patients along with concomitant improvements in the Wexner scores. For those using the device, there was less concern about accidental bowel leakage, high rates of satisfaction, and minimal problems with the device. Initial results are encouraging warranting further study.
